Tocilizumab for steroid refractory acute graft-versus-host disease

Acute graft-versus-host-disease (aGVHD) is a frequent and often lethal complication of allogeneic hematopoietic stem cell transplant despite prophylaxis. Tocilizumab is a humanized anti-IL-6 receptor monoclonal antibody that has evidence of activity in patients with steroid refractory (SR) GVHD. We...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leuk Lymphoma
Autors principals: Roddy, Julianna V. F., Haverkos, Bradley M., McBride, Ali, Leininger, Kathryn M., Jaglowski, Samantha, Penza, Sam, Klisovic, Rebecca, Blum, William, Vasu, Sumithira, Hofmeister, Craig C., Benson, Don M., Andritsos, Leslie A., Devine, Steven M., Efebera, Yvonne A.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698359/
https://ncbi.nlm.nih.gov/pubmed/26140610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2015.1045896
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars